Literature DB >> 22512476

Recent developments in buccal and sublingual delivery systems.

Sevda Şenel1, Michael J Rathbone, Merve Cansız, Indiran Pather.   

Abstract

INTRODUCTION: There have been several advances in the delivery of drugs through the buccal mucosa over the last 5 years, which have resulted in a number of new buccal delivery products appearing on the market. AREAS COVERED: This review discusses the most recent developments in the area of buccal and sublingual drug delivery, with a focus on marketed drugs. Likely future directions are also considered and reported. EXPERT OPINION: The future potential of buccal and sublingual delivery systems looks favorable. It is envisaged that in the future, buccal and sublingual delivery technologies will provide a platform for the successful delivery of vaccines and antigens. It is also foreseen that physical means of enhancing drug uptake (e.g., sonophoresis, iontophoresis and electroporation) will be commercialized for buccal delivery, thereby expanding the current drug candidate list for this area. The formulation of delivery systems for photosensitizers in photodynamic therapy is a potential emerging area, while buccal and sublingual delivery, in general, is attractive for the development of intellectual property.

Mesh:

Substances:

Year:  2012        PMID: 22512476     DOI: 10.1517/17425247.2012.676040

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  10 in total

1.  Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.

Authors:  Javier O Morales; Kristin R Fathe; Ashlee Brunaugh; Silvia Ferrati; Song Li; Miguel Montenegro-Nicolini; Zeynab Mousavikhamene; Jason T McConville; Mark R Prausnitz; Hugh D C Smyth
Journal:  AAPS J       Date:  2017-02-13       Impact factor: 4.009

Review 2.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

Review 3.  Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

Authors:  Vibhuti Agrahari; Vivek Agrahari; Ashim K Mitra
Journal:  Ther Deliv       Date:  2016

4.  Development of Optimized Sumatriptan-Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization.

Authors:  Sana Javed; Amjad Hussain; Pervaiz Akhtar Shah; Syed Atif Raza; Ubaid Ullah Anwer; Rahat Shamim; Fatima Rasool; Muhammad Ahsan Hafiz; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2022-06-02       Impact factor: 3.246

Review 5.  Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.

Authors:  Samir Mitragotri; Paul A Burke; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-08-08       Impact factor: 84.694

6.  A crossover clinical study to evaluate pain intensity from microneedle insertion in different parts of the oral cavity.

Authors:  Stephany Di Carla Santos; Nádia Cristina Fávaro-Moreira; Henrique Ballassin Abdalla; Gabriela Gama Xavier Augusto; Yuri Martins Costa; Maria Cristina Volpato; Francisco Carlos Groppo; Harvinder Singh Gill; Michelle Franz-Montan
Journal:  Int J Pharm       Date:  2020-11-05       Impact factor: 5.875

Review 7.  Chemopreventive potential of flavonoids in oral squamous cell carcinoma in human studies.

Authors:  Marcello Iriti; Elena Maria Varoni
Journal:  Nutrients       Date:  2013-07-08       Impact factor: 5.717

Review 8.  Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.

Authors:  Jenny K W Lam; Chucky C K Cheung; Michael Y T Chow; Emily Harrop; Susie Lapwood; Stephen I G Barclay; Ian C K Wong
Journal:  Adv Drug Deliv Rev       Date:  2020-11-01       Impact factor: 15.470

Review 9.  Nanocarriers-Assisted Needle-Free Vaccine Delivery Through Oral and Intranasal Transmucosal Routes: A Novel Therapeutic Conduit.

Authors:  Bharti Mangla; Shamama Javed; Muhammad H Sultan; Waquar Ahsan; Geeta Aggarwal; Kanchan Kohli
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

10.  Rapid Sublingual Delivery of Piroxicam from Electrospun Cyclodextrin Inclusion Complex Nanofibers.

Authors:  Fuat Topuz
Journal:  ACS Omega       Date:  2022-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.